Hydroxychloroquine trial begins in the UK

22 May, 2020

A trial to see whether two anti-malarial drugs could prevent Covid-19 has begun in Brighton and Oxford.

Chloroquine, hydroxychloroquine or a placebo will be given to more than 40,000 healthcare workers from Europe, Africa, Asia and South America.

All the participants are staff who are in contact with Covid-19 patients.

Click here for reference